Accuray Incorporated (LON:0H8I)

Market Cap	42.56M -76.7%
Revenue (ttm)	324.67M -3.6%
Net Income	-26.47M
EPS	-0.24
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,293
Average Volume	6,420
Open	0.5000
Previous Close	0.5048
Day's Range	0.5000 - 0.5221
52-Week Range	0.5012 - 2.4380
Beta	1.11
RSI	21.41
Earnings Date	Feb 4, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1990
• Employees: 990
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In fiscal year 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD